30-Mar-16 Major Malaysia pharma company Pharmaniaga Bhd expects its business in Indonesia to be profitable this year with a 1-2% growth in terms of contribution to its overall revenue. “In Indonesia currently, we have got common products manufactured there and we got high-end generic products in Malaysia, like cardiovascular products, that we can easily export,” managing director Datuk Farshila Emran said. [image: Pharmaniaga Bhd]

17-Mar-16 The Indian government has banned around 344 fixed dosed combination drugs, including Pfizer's cough syrup Corex, Procter & Gamble's Vicks Action 500 Extra and Crocin Cold and Flu, citing their potential risks. [image: Sajjad Hussain / AFP / Getty Images]

17-Mar-16 Medicine cost each Vietnamese USD37.9 on average in 2015, rising by 10% from the previous year and almost doubling the 2009 figure. Vietnam spends about USD3.4 bn on medication every year. [image: VNA]

16-Mar-16 Prenetics, a precision medicine company focused on personalized, predictive and preventive treatments, has announced a USD10 mn strategic investment led by China's Ping An Ventures. Other investors include Indonesia's Lippo Group backed Venturra Capital, Capital Union Investments and existing investors 500 Startups, COENT Venture Partners. [image: Prenetics]

08-Mar-16 According to a circular issued by China's State Council, generic drugs already available on the market should be assessed on whether they are consistent with brand-name drugs, and if they could be used clinically. Crucially, generics that pass the assessment will be included under national insurance coverage. [image: People's Daily Online]